We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.36B
AUM Growth
+$29.7M
Cap. Flow
-$20.3M
Cap. Flow %
-1.49%
Top 10 Hldgs %
35.2%
Holding
162
New
1
Increased
52
Reduced
28
Closed
4

Top Sells

Rank Stock Value
1
KEYS icon
Keysight
KEYS
+$11.3M
2
NVDA icon
NVIDIA
NVDA
+$9.75M
3
GEN icon
Gen Digital
GEN
+$4.52M
4
WFC icon
Wells Fargo
WFC
+$2.54M
5
WOOF
VCA Inc.
WOOF
+$2.37M

Sector Composition

Rank Sector Weight
1 Technology 35.88%
2 Financials 19.55%
3 Communication Services 14.81%
4 Healthcare 11.84%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAH icon
76
Cardinal Health
CAH
$53.4B
$3.59M 0.26%
53,650
VVX icon
77
V2X
VVX
$2.62B
$3.35M 0.25%
108,664
SNY icon
78
Sanofi
SNY
$104B
$3.35M 0.25%
67,200
ACH
79
Accendra Health
ACH
$240M
$3.33M 0.25%
114,200
UNH icon
80
UnitedHealth
UNH
$382B
$3.19M 0.24%
16,300
NVDA icon
81
NVIDIA
NVDA
$5.01T
$3.15M 0.23%
704,920
-2,345,280
-77% -$9.75M
MRVL icon
82
Marvell Technology
MRVL
$174B
$3.1M 0.23%
173,400
+19,000
+12% +$316K
CRL icon
83
Charles River Laboratories
CRL
$10.9B
$3.07M 0.23%
28,450
AET
84
DELISTED
Aetna Inc
AET
$2.92M 0.22%
18,380
-1,080
-6% -$169K
JNJ icon
85
Johnson & Johnson
JNJ
$635B
$2.82M 0.21%
21,700
CI icon
86
Cigna
CI
$76.6B
$2.62M 0.19%
14,000
DGX icon
87
Quest Diagnostics
DGX
$25.1B
$2.51M 0.18%
26,800
-4,300
-14% -$456K
MRK icon
88
Merck
MRK
$324B
$2.43M 0.18%
39,824
-2,515
-6% -$152K
SYK icon
89
Stryker
SYK
$127B
$2.43M 0.18%
17,110
-200
-1% -$28.7K
ENS icon
90
EnerSys
ENS
$6.95B
$2.22M 0.16%
32,122
-23,690
-42% -$1.62M
GSBC icon
91
Great Southern Bancorp
GSBC
$863M
$2.14M 0.16%
38,457
-130
-0.3% -$6.68K
SYF icon
92
Synchrony
SYF
$23.7B
$2.09M 0.15%
67,415
+59,065
+707% +$1.77M
CRUS icon
93
Cirrus Logic
CRUS
$6.74B
$2.04M 0.15%
38,215
BIDU icon
94
Baidu
BIDU
$35.8B
$2.02M 0.15%
8,150
LLY icon
95
Eli Lilly
LLY
$1.07T
$1.93M 0.14%
22,500
FTNT icon
96
Fortinet
FTNT
$112B
$1.82M 0.13%
254,175
TECK icon
97
Teck Resources
TECK
$29.5B
$1.77M 0.13%
83,874
+4,250
+5% +$92.5K
NBR icon
98
Nabors Industries
NBR
$1.23B
$1.73M 0.13%
4,282
-164
-4% -$60K
LRCX icon
99
Lam Research
LRCX
$382B
$1.71M 0.13%
92,550
NXGN
100
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$1.51M 0.11%
96,210

Similar funds

Oak Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Oak Associates held 162 positions worth $1.36B, up 2.2% from $1.33B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 3.1%. Oak Associates opened 1 new position and exited 4, leaving the 162-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Communication Services.

  • Oak Associates's largest Q3 2017 buy was Gilead Sciences: 2,585 shares worth $209K.
  • Oak Associates added most to Check Point Software Technologies in Q3 2017, an estimated $4.29M increase.
  • Oak Associates's biggest Q3 2017 reduction was NVIDIA, cutting an estimated $9.75M.
  • Oak Associates fully exited Keysight in Q3 2017, selling an estimated $11.3M.
  • Oak Associates's ten largest holdings make up 35% of its $1.36B portfolio in Q3 2017.
  • Oak Associates opened 1 new position and closed 4 in Q3 2017.
  • Oak Associates's portfolio value rose 2.2% quarter-over-quarter to $1.36B.

Based on Oak Associates's 13F filing for Q3 2017, filed 7 Nov 2017.